Streptococcus pyogenes C 203 M is a facultative anaerobe, Gram-positive, coccus-shaped bacterium of the family Streptococcaceae.
Gram-positive coccus-shaped facultative anaerobe Bacteria| @ref 20215 |
|
|
| Domain Bacteria |
| Phylum Bacillota |
| Class Bacilli |
| Order Lactobacillales |
| Family Streptococcaceae |
| Genus Streptococcus |
| Species Streptococcus pyogenes |
| Full scientific name Streptococcus pyogenes Rosenbach 1884 (Approved Lists 1980) |
| @ref | Name | Growth | Composition | Medium link | |
|---|---|---|---|---|---|
| 39833 | MEDIUM 29- Brain heart agar | Distilled water make up to (1000.000 ml);Brain heart infusion agar (52.000 g) | |||
| 39833 | CIP Medium 29 | Medium recipe at CIP |
| 39833 | Oxygen tolerancefacultative anaerobe |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68371 | 27613 ChEBI | amygdalin | - | builds acid from | from API 50CH acid |
| 68371 | 18305 ChEBI | arbutin | - | builds acid from | from API 50CH acid |
| 68371 | 17057 ChEBI | cellobiose | + | builds acid from | from API 50CH acid |
| 68371 | 17108 ChEBI | D-arabinose | - | builds acid from | from API 50CH acid |
| 68371 | 18333 ChEBI | D-arabitol | - | builds acid from | from API 50CH acid |
| 68371 | 15824 ChEBI | D-fructose | + | builds acid from | from API 50CH acid |
| 68371 | 28847 ChEBI | D-fucose | - | builds acid from | from API 50CH acid |
| 68371 | 12936 ChEBI | D-galactose | - | builds acid from | from API 50CH acid |
| 68371 | 17634 ChEBI | D-glucose | + | builds acid from | from API 50CH acid |
| 68371 | 62318 ChEBI | D-lyxose | - | builds acid from | from API 50CH acid |
| 68371 | 16899 ChEBI | D-mannitol | - | builds acid from | from API 50CH acid |
| 68371 | 16024 ChEBI | D-mannose | + | builds acid from | from API 50CH acid |
| 68371 | 17924 ChEBI | D-sorbitol | - | builds acid from | from API 50CH acid |
| 68371 | 16443 ChEBI | D-tagatose | - | builds acid from | from API 50CH acid |
| 68371 | 65327 ChEBI | D-xylose | - | builds acid from | from API 50CH acid |
| 68371 | 17113 ChEBI | erythritol | - | builds acid from | from API 50CH acid |
| 39833 | 4853 ChEBI | esculin | - | hydrolysis | |
| 68371 | 4853 ChEBI | esculin | - | builds acid from | from API 50CH acid |
| 68371 | 16813 ChEBI | galactitol | - | builds acid from | from API 50CH acid |
| 68371 | 28066 ChEBI | gentiobiose | - | builds acid from | from API 50CH acid |
| 68371 | 24265 ChEBI | gluconate | - | builds acid from | from API 50CH acid |
| 68371 | 17754 ChEBI | glycerol | - | builds acid from | from API 50CH acid |
| 68371 | 15443 ChEBI | inulin | - | builds acid from | from API 50CH acid |
| 68371 | 30849 ChEBI | L-arabinose | - | builds acid from | from API 50CH acid |
| 68371 | 18403 ChEBI | L-arabitol | - | builds acid from | from API 50CH acid |
| 68371 | 18287 ChEBI | L-fucose | - | builds acid from | from API 50CH acid |
| 68371 | 62345 ChEBI | L-rhamnose | - | builds acid from | from API 50CH acid |
| 68371 | 17266 ChEBI | L-sorbose | - | builds acid from | from API 50CH acid |
| 68371 | 65328 ChEBI | L-xylose | - | builds acid from | from API 50CH acid |
| 68371 | 17716 ChEBI | lactose | - | builds acid from | from API 50CH acid |
| 68371 | 17306 ChEBI | maltose | + | builds acid from | from API 50CH acid |
| 68371 | 6731 ChEBI | melezitose | - | builds acid from | from API 50CH acid |
| 68371 | 28053 ChEBI | melibiose | - | builds acid from | from API 50CH acid |
| 68371 | 320061 ChEBI | methyl alpha-D-glucopyranoside | + | builds acid from | from API 50CH acid |
| 68371 | 43943 ChEBI | methyl alpha-D-mannoside | - | builds acid from | from API 50CH acid |
| 68371 | 74863 ChEBI | methyl beta-D-xylopyranoside | - | builds acid from | from API 50CH acid |
| 68371 | 17268 ChEBI | myo-inositol | - | builds acid from | from API 50CH acid |
| 68371 | 59640 ChEBI | N-acetylglucosamine | + | builds acid from | from API 50CH acid |
| 39833 | 17632 ChEBI | nitrate | - | reduction | |
| 39833 | 16301 ChEBI | nitrite | - | reduction | |
| 68371 | Potassium 2-ketogluconate | - | builds acid from | from API 50CH acid | |
| 68371 | 16634 ChEBI | raffinose | - | builds acid from | from API 50CH acid |
| 68371 | 15963 ChEBI | ribitol | - | builds acid from | from API 50CH acid |
| 68371 | 17814 ChEBI | salicin | - | builds acid from | from API 50CH acid |
| 68371 | 28017 ChEBI | starch | + | builds acid from | from API 50CH acid |
| 68371 | 17992 ChEBI | sucrose | + | builds acid from | from API 50CH acid |
| 68371 | 27082 ChEBI | trehalose | - | builds acid from | from API 50CH acid |
| 68371 | 32528 ChEBI | turanose | - | builds acid from | from API 50CH acid |
| 68371 | 17151 ChEBI | xylitol | - | builds acid from | from API 50CH acid |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68382 | acid phosphatase | - | 3.1.3.2 | from API zym |
| 39833 | alcohol dehydrogenase | + | 1.1.1.1 | |
| 68382 | alkaline phosphatase | - | 3.1.3.1 | from API zym |
| 68382 | alpha-chymotrypsin | - | 3.4.21.1 | from API zym |
| 68382 | alpha-fucosidase | - | 3.2.1.51 | from API zym |
| 68382 | alpha-galactosidase | - | 3.2.1.22 | from API zym |
| 68382 | alpha-glucosidase | - | 3.2.1.20 | from API zym |
| 68382 | alpha-mannosidase | - | 3.2.1.24 | from API zym |
| 39833 | beta-galactosidase | + | 3.2.1.23 | |
| 68382 | beta-galactosidase | - | 3.2.1.23 | from API zym |
| 68382 | beta-glucosidase | - | 3.2.1.21 | from API zym |
| 68382 | beta-glucuronidase | - | 3.2.1.31 | from API zym |
| 39833 | catalase | - | 1.11.1.6 | |
| 68382 | cystine arylamidase | - | 3.4.11.3 | from API zym |
| 68382 | esterase (C 4) | - | from API zym | |
| 68382 | esterase lipase (C 8) | - | from API zym | |
| 68382 | leucine arylamidase | - | 3.4.11.1 | from API zym |
| 68382 | lipase (C 14) | - | from API zym | |
| 39833 | lysine decarboxylase | - | 4.1.1.18 | |
| 68382 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 | from API zym |
| 68382 | naphthol-AS-BI-phosphohydrolase | - | from API zym | |
| 39833 | ornithine decarboxylase | - | 4.1.1.17 | |
| 68382 | trypsin | - | 3.4.21.4 | from API zym |
| 68382 | valine arylamidase | - | from API zym |
| @ref | ControlQ | GLY | ERY | DARA | LARA | RIB | DXYL | LXYL | ADO | MDX | GAL | GLU | FRU | MNE | SBE | RHA | DUL | INO | MAN | SOR | MDM | MDG | NAG | AMY | ARB | ESC | SAL | CEL | MAL | LAC | MEL | SAC | TRE | INU | MLZ | RAF | AMD | GLYG | XLT | GEN | TUR | LYX | TAG | DFUC | LFUC | DARL | LARL | GNT | 2KG | 5KG | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 39833 | not determinedn.d. | - | - | - | - | +/- | - | - | - | - | - | + | + | + | - | - | - | - | - | - | - | + | + | - | - | - | - | + | + | - | - | + | - | - | - | - | + | +/- | - | - | - | - | - | - | - | - | - | - | - | +/- |
| @ref | Biosafety level | Biosafety level comment | |
|---|---|---|---|
| 39833 | 2 | Risk group (French classification) |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Antibacterial and Antibiofilm Properties of Postbiotics Derived from Lactiplantibacillus pentosus B1. | Nowak-Lange M, Niedzialkowska K, Tonczyk A, Parolin C, Vitali B, Lisowska K. | Int J Mol Sci | 10.3390/ijms26178169 | 2025 | ||
| Phytochemical components and antibacterial activity of two populations of Senecio vulgaris L. essential oils as traditional medicine plant | Hajmoradi F, Fathi H, Moghadami F. | Iran J Microbiol | 2025 | |||
| Lactiplantibacillus plantarum KAU007 Extract Modulates Critical Virulence Attributes and Biofilm Formation in Sinusitis Causing Streptococcus pyogenes. | Rather IA, Wani MY, Kamli MR, Sabir JSM, Hakeem KR, Firoz A, Park YH, Hor YY. | Pharmaceutics | 10.3390/pharmaceutics14122702 | 2022 | ||
| Design, synthesis, antimicrobial, antibiofilm evaluation and Z/E-isomerization of novel 6-((arylamino)methylene)benzo[a] phenazin-5(6H)-ones induced by organic solvent. | Olyaei A, Ghaleghovandi N, Moghadami F, Sadeghpour M, Abediha S. | RSC Adv | 10.1039/d3ra05788g | 2023 | ||
| Efficacy of Surgical/Wound Washes against Bacteria: Effect of Different In Vitro Models. | Parvin F, Vickery K, Deva AK, Hu H. | Materials (Basel) | 10.3390/ma15103630 | 2022 | ||
| Metabolism | Antimicrobial activity of Anonna mucosa (Jacq.) grown in vivo and obtained by in vitroculture. | Barboza TJ, Ferreira AF, Ignacio AC, Albarello N. | Braz J Microbiol | 10.1590/s1517-838246320140468 | 2015 | |
| Chemical Composition and Antimicrobial Activities of the Essential Oil From Salvia mirzayanii Leaves. | Zomorodian K, Moein M, Pakshir K, Karami F, Sabahi Z. | J Evid Based Complementary Altern Med | 10.1177/2156587217717414 | 2017 | ||
| Eravacycline (TP-434) is efficacious in animal models of infection. | Grossman TH, Murphy TM, Slee AM, Lofland D, Sutcliffe JA. | Antimicrob Agents Chemother | 10.1128/aac.04354-14 | 2015 | ||
| Phytochemical and biological activities of some Iranian medicinal plants. | Dini S, Chen Q, Fatemi F, Asri Y. | Pharm Biol | 10.1080/13880209.2022.2046112 | 2022 | ||
| Mining the heparinome for cryptic antimicrobial peptides that selectively kill Gram-negative bacteria. | Bello-Madruga R, Sandin D, Valle J, Gomez J, Comas L, Larrosa MN, Gonzalez-Lopez JJ, Jimenez MA, Andreu D, Torrent M. | Mol Syst Biol | 10.1038/s44320-025-00120-6 | 2025 | ||
| Cloning and expression of the enzymatic region of Streptococcal hyaluronidase. | Mirjamali NA, Soufian S, Molaee N, Abbasian SS, Abtahi H. | Iran J Basic Med Sci | 2014 | |||
| Phylogeny | Isolation and Identification of Phyllospheric Bacteria Possessing Antimicrobial Activity from Astragalus obtusifolius, Prosopis juliflora, Xanthium strumarium and Hippocrepis unisiliqousa. | Mazinani Z, Zamani M, Sardari S. | Avicenna J Med Biotechnol | 2017 | ||
| Lamiaceae Essential Oils, Phytochemical Profile, Antioxidant, and Biological Activities. | Ramos da Silva LR, Ferreira OO, Cruz JN, de Jesus Pereira Franco C, Oliveira Dos Anjos T, Cascaes MM, Almeida da Costa W, Helena de Aguiar Andrade E, Santana de Oliveira M. | Evid Based Complement Alternat Med | 10.1155/2021/6748052 | 2021 | ||
| Molecular Diagnosis of Bacterial Definite Infective Endocarditis by Real-Time Polymerase Chain Reaction. | Faraji R, Behjati-Ardakani M, Faraji N, Moshtaghioun SM, Kalantar SM, Pedarzadeh A, Zandi H, Sarebanhassanabadi M, Ahmadi N, Dehghani Firoozabadi A. | Cardiol Res | 10.14740/cr687w | 2018 | ||
| Expression of recombinant streptokinase from streptococcus pyogenes and its reaction with infected human and murine sera. | Molaee N, Abtahi H, Mosayebi G. | Iran J Basic Med Sci | 2013 | |||
| Thymus musilii Velen. Methanolic Extract: In Vitro and In Silico Screening of Its Antimicrobial, Antioxidant, Anti-Quorum Sensing, Antibiofilm, and Anticancer Activities. | Noumi E, Ahmad I, Bouali N, Patel H, Ghannay S, ALrashidi AA, Abdulhakeem MA, Patel M, Ceylan O, Badraoui R, Mousa Elayyan AE, Adnan M, Kadri A, Snoussi M. | Life (Basel) | 10.3390/life13010062 | 2022 | ||
| Phytochemistry, nutritional composition, and pharmacological activities of Thaumatococcus daniellii (Benth): a review. | Fadahunsi O, Adegbola PI, Olorunnisola SO, Akinloye OA. | BioTechnologia (Pozn) | 10.5114/bta.2021.103766 | 2021 | ||
| Antimicrobial and Antioxidant Activities of Pycnocycla spinosa Extracts. | Mahboubi M, Taghizadeh M, Kazempour N. | Jundishapur J Nat Pharm Prod | 10.17795/jjnpp-13859 | 2014 | ||
| Metabolism | Lipase and biosurfactant from Ochrobactrum intermedium strain MZV101 isolated by washing powder for detergent application. | Zarinviarsagh M, Ebrahimipour G, Sadeghi H. | Lipids Health Dis | 10.1186/s12944-017-0565-8 | 2017 | |
| Biochemical Activities of Iranian Cymbopogon olivieri (Boiss) Bor. Essential Oil. | Mahboubi M, Kazempour N. | Indian J Pharm Sci | 10.4103/0250-474x.107071 | 2012 | ||
| Phylogeny | Antimicrobial activity of euplotin C, the sesquiterpene taxonomic marker from the marine ciliate Euplotes crassus. | Savoia D, Avanzini C, Allice T, Callone E, Guella G, Dini F. | Antimicrob Agents Chemother | 10.1128/aac.48.10.3828-3833.2004 | 2004 | |
| Application of bacteriocins in food preservation and infectious disease treatment for humans and livestock: a review. | Ng ZJ, Zarin MA, Lee CK, Tan JS. | RSC Adv | 10.1039/d0ra06161a | 2020 | ||
| Pathogenicity | In vitro and in vivo antibacterial activities of DW286, a new fluoronaphthyridone antibiotic. | Yun HJ, Min YH, Lim JA, Kang JW, Kim SY, Kim MJ, Jeong JH, Choi YJ, Kwon HJ, Jung YH, Shim MJ, Choi EC. | Antimicrob Agents Chemother | 10.1128/aac.46.9.3071-3074.2002 | 2002 | |
| Metabolism | Import and metabolism of glutathione by Streptococcus mutans. | Sherrill C, Fahey RC. | J Bacteriol | 10.1128/jb.180.6.1454-1459.1998 | 1998 | |
| Commercial Essential Oils as Potential Antimicrobials to Treat Skin Diseases. | Orchard A, van Vuuren S. | Evid Based Complement Alternat Med | 10.1155/2017/4517971 | 2017 | ||
| Enhancement of bacterial infections in mice by newcastle disease virus. | Hugh R, Huang KY, Elliott TB. | Infect Immun | 10.1128/iai.3.3.488-493.1971 | 1971 | ||
| Pathogenicity | Antimicrobial activities of 81.723 hfu, a new pleuromutilin derivative. | Drews J, Georgopoulos A, Laber G, Schutze E, Unger J. | Antimicrob Agents Chemother | 10.1128/aac.7.5.507 | 1975 | |
| In-vitro and in-vivo antibacterial activity of CFC-222, a new fluoroquinolone. | Kim JH, Choi KH, Kim JW, Lee JH, Choi EC, Kim BK | J Antimicrob Chemother | 10.1093/jac/41.2.223 | 1998 |
| #20215 | Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 ) |
| #39833 | Collection of Institut Pasteur ; Curators of the CIP; CIP 54.5 |
| #68371 | Automatically annotated from API 50CH acid . |
| #68382 | Automatically annotated from API zym . |
| #126262 | A. Lissin, I. Schober, J. F. Witte, H. Lüken, A. Podstawka, J. Koblitz, B. Bunk, P. Dawyndt, P. Vandamme, P. de Vos, J. Overmann, L. C. Reimer: StrainInfo—the central database for linked microbial strain identifiers. ( DOI 10.1093/database/baaf059 ) |
You found an error in BacDive? Please tell us about it!
Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.
Successfully sent
If you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive138478.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data